Related content

Short-term androgen deprivation and PSA doubling time: their association and relationship to disease progression after radiation therapy for prostate cancer

By Hanlon A.L.   Horwitz E.M.   Hanks G.E.   Pollack A.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP)

By Kitagawa Yasuhide   Ueno Satoru   Izumi Kouji   Mizokami Atsushi   Hinotsu Shiro   Akaza Hideyuki   Namiki Mikio  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 4, 2014-04 ,pp. : 673-679

Springer Publishing Company

Access to resources Recommend Favorite

Trends in the use of androgen deprivation in prostate cancer

By Salminen Eeva   Wickström Jan-Erik   Vahlberg Tero   Duchesne Gillian  

Acta Oncologica, Vol. 43, Iss. 4, 2004-06 ,pp. : 382-387

Informa Healthcare

Access to resources Recommend Favorite

Intermittent Androgen Deprivation Therapy in Advanced Prostate Cancer

By Alva Ajjai   Hussain Maha  

Current Treatment Options in Oncology, Vol. 15, Iss. 1, 2014-03 ,pp. : 127-136

Springer Publishing Company

Access to resources Recommend Favorite

Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer?

By Nguyen K.H.   Horwitz E.M.   Hanlon A.L.   Uzzo R.G.   Pollack A.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 377-383

Elsevier

Access to resources Recommend Favorite